Fisher & Paykel Healthcare (NZSE:FPH) Interest Expense : NZ$-14 Mil (TTM As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fisher & Paykel Healthcare's interest expense for the six months ended in Sep. 2023 was NZ$ -9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$-14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fisher & Paykel Healthcare's Operating Income for the six months ended in Sep. 2023 was NZ$ 110 Mil. Fisher & Paykel Healthcare's Interest Expense for the six months ended in Sep. 2023 was NZ$ -9 Mil. Fisher & Paykel Healthcare's Interest Coverage for the quarter that ended in Sep. 2023 was 12.68. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fisher & Paykel Healthcare Interest Expense Historical Data

The historical data trend for Fisher & Paykel Healthcare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Interest Expense Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-4.70

-3.90

-5.00

-4.90

-6.70

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Interest Expense	Get a 7-Day Free Trial															-2.40	-2.50	-1.20	-5.50	-8.70

Fisher & Paykel Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$-14 Mil.

Fisher & Paykel Healthcare (NZSE:FPH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fisher & Paykel Healthcare's Interest Expense for the six months ended in Sep. 2023 was NZ$-9 Mil. Its Operating Income for the six months ended in Sep. 2023 was NZ$110 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was NZ$300 Mil.

Fisher & Paykel Healthcare's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2023 )	/	Interest Expense (Q: Sep. 2023 )
	=	-1	*	110.3	/	-8.7
	=	12.68

The higher the ratio, the stronger the company's financial strength is.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.